Anliang Xia
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 6
- RNA Research and Splicing 4
-
- Cancer-related molecular mechanisms research 6
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Xiaojie Lu (5 shared papers)Beicheng Sun (8 shared papers)Xiaochen Wang (3 shared papers)Qifeng He (4 shared papers)Yan Zhang (1 shared paper)Xu Jiang (1 shared paper)Tailang Yin (1 shared paper)Wenfang Tian (2 shared papers)
In The Last Decade
Anliang Xia
18 papers receiving 953 citations
Peers
Comparison fields: 5 of 78
- Immunology 379
- Cancer Research 260
- Oncology 469
- Hepatology 56
- Molecular Biology 455
Countries citing papers authored by Anliang Xia
This map shows the geographic impact of Anliang Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anliang Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anliang Xia more than expected).
Fields of papers citing papers by Anliang Xia
This network shows the impact of papers produced by Anliang Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anliang Xia. The network helps show where Anliang Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Anliang Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 247 | |
| 2 | 2019 | 213 | |
| 3 | 2017 | 100 | |
| 4 | 2022 | 73 | |
| 5 | 2018 | 70 | |
| 6 | 2022 | 59 | |
| 7 | 2018 | 40 | |
| 8 | 2018 | 38 | |
| 9 | 2019 | 33 | |
| 10 | 2016 | 25 | |
| 11 | 2024 | 13 | |
| 12 | 2023 | 12 | |
| 13 | 2021 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2018 | 8 | |
| 16 | 2023 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2025 | 1 |
About Anliang Xia
Anliang Xia is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 960 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers), CAR-T cell therapy research (5 papers), RNA Research and Splicing (4 papers), Immune Cell Function and Interaction (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Immunology (379 citations), Cancer Research (260 citations), Oncology (469 citations), Hepatology (56 citations) and Molecular Biology (455 citations). Anliang Xia has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Xiaojie Lu, Beicheng Sun, Xiaochen Wang, Qifeng He, Yan Zhang, Xu Jiang, Tailang Yin, Wenfang Tian, Haiyuan Shen and Weiwei Yu. Their work appears in journals such as Journal of Medical Genetics, Cell Death Discovery, Helicobacter, Journal of Hepatology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.